Bitcoin halving
What does that mean?
$2.79T
Total marketcap
$111.92B
Total volume
BTC 49.69%     ETH 15.38%
Dominance

Chugai Pharmaceutical Co., Ltd. CHGCY Stock

19.13 USD {{ price }} -2.173363% {{change_pct}}%
Exchange
Other OTC
Market Cap
62.95B USD
LOW - HIGH [24H]
18.45 - 19.65 USD
VOLUME [24H]
38.07K USD
{{ volume }}
P/E Ratio
29.43
Earnings per share
0.65 USD

Chugai Pharmaceutical Co., Ltd. Price Chart

Chugai Pharmaceutical Co., Ltd. CHGCY Financial and Trading Overview

Chugai Pharmaceutical Co., Ltd. stock price 19.13 USD
Previous Close 14.96 USD
Open 14.85 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 14.65 - 14.85 USD
52 Week Range 10.99 - 15.11 USD
Volume 27.18K USD
Avg. Volume 74.7K USD
Market Cap 48.63B USD
Beta (5Y Monthly) 0.488888
PE Ratio (TTM) 21.745588
EPS (TTM) 0.65 USD
Forward Dividend & Yield 0.29 (1.91%)
Ex-Dividend Date December 29, 2022
1y Target Est N/A

CHGCY Valuation Measures

Enterprise Value -505391644672 USD
Trailing P/E 21.745588
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.04013522
Price/Book (mrq) 0.03385926
Enterprise Value/Revenue -0.417
Enterprise Value/EBITDA -1.061

Trading Information

Chugai Pharmaceutical Co., Ltd. Stock Price History

Beta (5Y Monthly) 0.488888
52-Week Change 20.21%
S&P500 52-Week Change 20.43%
52 Week High 15.11 USD
52 Week Low 10.99 USD
50-Day Moving Average 13.2 USD
200-Day Moving Average 12.73 USD

CHGCY Share Statistics

Avg. Volume (3 month) 74.7K USD
Avg. Daily Volume (10-Days) 44.89K USD
Shares Outstanding 3.29B
Float 1.28B
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0.016%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 78
Trailing Annual Dividend Yield 521.39%
5 Year Average Dividend Yield 154.00%
Payout Ratio 0.39990002
Last Split Factor 12:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 26.09%
Operating Margin (ttm) 36.69%
Gross Margin 57.64%
EBITDA Margin 39.30%

Management Effectiveness

Return on Assets (ttm) 16.55%
Return on Equity (ttm) 23.61%

Income Statement

Revenue (ttm) 1.21T USD
Revenue Per Share (ttm) 368.28 USD
Quarterly Revenue Growth (yoy) -13.40%
Gross Profit (ttm) 783.7B USD
EBITDA 476.23B USD
Net Income Avi to Common (ttm) 316.15B USD
Diluted EPS (ttm) 0.68
Quarterly Earnings Growth (yoy) -44.20%

Balance Sheet

Total Cash (mrq) 554.61B USD
Total Cash Per Share (mrq) 168.56 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 3.893
Book Value Per Share (mrq) 436.7195

Cash Flow Statement

Operating Cash Flow (ttm) 299.32B USD
Levered Free Cash Flow (ttm) 244.3B USD

Profile of Chugai Pharmaceutical Co., Ltd.

Country United States
State N/A
City Chuo
Address 2-1-1 Nihonbashi-Muromachi
ZIP 103-8324
Phone 81 3 3281 6611
Website https://www.chugai-pharm.co.jp
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 7771

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.

Q&A For Chugai Pharmaceutical Co., Ltd. Stock

What is a current CHGCY stock price?

Chugai Pharmaceutical Co., Ltd. CHGCY stock price today per share is 19.13 USD.

How to purchase Chugai Pharmaceutical Co., Ltd. stock?

You can buy CHGCY shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Chugai Pharmaceutical Co., Ltd.?

The stock symbol or ticker of Chugai Pharmaceutical Co., Ltd. is CHGCY.

Which industry does the Chugai Pharmaceutical Co., Ltd. company belong to?

The Chugai Pharmaceutical Co., Ltd. industry is Drug Manufacturers-General.

How many shares does Chugai Pharmaceutical Co., Ltd. have in circulation?

The max supply of Chugai Pharmaceutical Co., Ltd. shares is 3.29B.

What is Chugai Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?

Chugai Pharmaceutical Co., Ltd. PE Ratio is 29.43076900 now.

What was Chugai Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?

Chugai Pharmaceutical Co., Ltd. EPS is 0.65 USD over the trailing 12 months.

Which sector does the Chugai Pharmaceutical Co., Ltd. company belong to?

The Chugai Pharmaceutical Co., Ltd. sector is Healthcare.